RecruitingNCT05452291
Multiomics Biomarkers for Urolithiasis
Exploring Multiomics Biomarkers for Urolithiasis
Sponsor
Chinese University of Hong Kong
Enrollment
1,200 participants
Start Date
May 27, 2022
Study Type
OBSERVATIONAL
Conditions
Summary
This is a prospective case series study. To compare urine sample of recurrent stone-formers and non-stone former by multiomics approach to identify potential markers for stone recurrence.
Eligibility
Min Age: 18 Years
Plain Language Summary
Simplified for easier understanding
This clinical trial is studying a new treatment for people with urolithiasis. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years and older.
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05452291
Related Trials
Trial of Ureteroscopy vs Steerable Continuous Flow Aspiration Technology
NCT071018095 locations
Effects of Virtual Reality Education on Anxiety and Learning in Patients Undergoing Urolithiasis Surgery
NCT076208731 location
COMPARISON OF FANS VS CONVENTIONAL URETERAL ACCESS SHEATH in RIRS on POSTOPERATIVE ACUTE KIDNEY INJURY
NCT076855871 location
PMCF Investigation of MODULITH® SLX-F2 With StorM-Track in Patients With Kidney Stones
NCT072727201 location
Antibiotic Irrigation and Suction Ureteral Access Sheath in RIRS
NCT076550502 locations